Rituxan SC (rituximab)

pCPA File Number: 21290
Negotiation Status:
Active Negotiation
Indication(s):
Chronic Lymphocytic Leukemia
Sponsor/Manufacturer:
Hoffmann-La Roche
CADTH Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable